Haemonetics Corp. (HAE)
57.61
+0.11
(+0.19%)
USD |
NYSE |
Feb 12, 16:00
57.61
0.00 (0.00%)
After-Hours: 20:00
Haemonetics Price : 57.61 for Feb. 12, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| DexCom, Inc. | 65.08 |
| Celldex Therapeutics, Inc. | 23.44 |
| Atossa Therapeutics, Inc. | 3.88 |
| Abeona Therapeutics, Inc. | 4.995 |
| Cell Source, Inc. | 0.85 |
Price Related Metrics
| PE Ratio | 15.83 |
| PS Ratio | 2.103 |
| PEG Ratio | 0.3662 |
| Price to Book Value | 2.937 |
| Price to Free Cash Flow | 8.998 |
| Earnings Yield | 6.32% |
| Market Cap | 2.677B |
| PEGY Ratio | 0.3662 |
| Operating PE Ratio | 11.39 |
| Normalized PE Ratio | 15.80 |